These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36576239)

  • 21. Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: a single center experience.
    Woo SM; Son BH; Lee JW; Kim HJ; Yu JH; Ko BS; Sohn G; Lee YR; Kim H; Ahn SH; Baek SH
    J Breast Cancer; 2013 Dec; 16(4):410-6. PubMed ID: 24454463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes.
    Terada M; Adachi Y; Sawaki M; Hattori M; Yoshimura A; Naomi G; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Mori M; Horisawa N; Sasaki E; Yatabe Y; Iwata H
    Breast Cancer Res Treat; 2018 Nov; 172(1):1-7. PubMed ID: 30030707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
    Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
    Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis.
    Johnson HM; Irish W; Vohra NA; Wong JH
    Breast Cancer Res Treat; 2019 Aug; 177(1):155-164. PubMed ID: 31127469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study.
    Zhang D; Zhai J; Li L; Wu Y; Ma F; Xu B
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes.
    Joo JH; Kim SS; Son BH; Ahn SD; Jung JH; Choi EK; Ahn SH; Lee JW; Kim HJ; Ko BS
    Cancer Res Treat; 2019 Jul; 51(3):1011-1021. PubMed ID: 30322228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
    Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
    Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
    Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
    Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Li H; Chen Y; Wang X; Tang L; Guan X
    Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database.
    Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR
    Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review.
    Xu R; Li J; Zhang Y; Jing H; Zhu Y
    Medicine (Baltimore); 2017 Dec; 96(51):e9312. PubMed ID: 29390502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy.
    Lim SZ; Kusumawidjaja G; Mohd Ishak HM; Tan BKT; Tan SY; Hamzah JL; Madhukumar P; Yong WS; Wong CY; Sim Y; Lim GH; Lim SH; Tan SM; Wong FY; Tan VKM
    Breast Cancer Res Treat; 2021 Oct; 189(3):837-843. PubMed ID: 34342766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports.
    Yang H; Li L; Zhang M; Zhang S; Xu S; Ma X
    Medicine (Baltimore); 2017 Oct; 96(40):e8200. PubMed ID: 28984771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
    Guo L; Xie G; Wang R; Yang L; Sun L; Xu M; Yang W; Chung MC
    BMC Cancer; 2021 Jun; 21(1):717. PubMed ID: 34147061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.
    Picado O; Khazeni K; Allen C; Yakoub D; Avisar E; Kesmodel SB
    Breast Cancer Res Treat; 2018 Sep; 171(2):461-469. PubMed ID: 29869773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic analysis of cT1-3N1M0 breast cancer patients who have responded to neoadjuvant therapy undergoing various axillary surgery and breast surgery based on propensity score matching and competitive risk model.
    Zhang M; Sun Y; Wu H; Xiao J; Chen W; Wang H; Yang B; Luo H
    Front Oncol; 2024; 14():1319981. PubMed ID: 38327751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Neoadjuvant Versus Adjuvant Chemotherapy on the Extent of Axillary Surgery for Clinically Node-Negative Breast Cancers of Triple-Negative and HER2-Overexpressing Phenotypes.
    Thompson JL; Wrubel E; Davis AT; Koehler T; Chung MH; Wright GP
    Clin Breast Cancer; 2020 Oct; 20(5):390-394. PubMed ID: 32444317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Male Patients With Occult Breast Cancer: Analysis of the National Cancer Database.
    Wong WG; Perez Holguin RA; Kanwar R; Dodge D; Shen C
    J Surg Res; 2024 Jan; 293():685-692. PubMed ID: 37839100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.